FDA Panel Recommends Against Wider Use of Zimmer’s Dynesys Spinal System

An FDA advisory panel of medical experts has recommended against proposed wider use of Zimmer’s Dynesys spine stabilization device, according to a report by Reuters.

Advertisement

Zimmer is asking for stand-alone use of Dynesys, a series of screws and flexible spacers that aim to help align and support the spine, which is already approved for use in patients with back problems who undergo surgical fusion.

Panel members questioned how the device would hold up over time and expressed concern about possible breakage, but they added that the device holds promise.

Read Reuters’ report on Zimmer’s Dynesys spinal device.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Providence Medical Technology, a spinal technology company, has appointed Lane Major as president and CEO. Mr. Major also joined the…

  • Alphatec Holdings reported total revenue of $214 million for the second quarter ended June 30, up 15% year over year.…

Advertisement

Comments are closed.